SCHEMBL18735171

SCHEMBL18735171

CCC(C)C(=O)NC(CSC(=O)CC(=O)OC(C)C)C(=O)N(CC)CC

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.33
▸ LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735188 0.90 ALOX15 (0.32) ALOX15LMNA
SCHEMBL18735152 0.90 — —
SCHEMBL18734969 0.88 — —
SCHEMBL18734927 0.88 ALOX15 (0.32) ALOX15
SCHEMBL18735173 0.88 MGAM (0.33) —
SCHEMBL18735180 0.85 ALOX15 (0.32) ALOX15LMNA
SCHEMBL18734931 0.83 — —
SCHEMBL18735067 0.82 CYP1A2 (0.36) ALOX15LMNA
SCHEMBL18734942 0.81 METAP2 (0.30) —
SCHEMBL18735170 0.80 CNR2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback